Mel-18 controls the enrichment of tumor-initiating cells in SP fraction in mouse breast cancer.
In conclusion, our findings revealed the significance of fine-tuning mechanisms for Mel-18 protein expression level in the maintenance of TIC into SP fractions in mouse breast cancer.
PMID: 21970185 [PubMed - indexed for MEDLINE]
Source: Hiroshima Journal of Medical Sciences - Category: Journals (General) Tags: Hiroshima J Med Sci Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | General Medicine | Genetics | Stem Cell Therapy | Stem Cells | Study | Tics | Transplants